相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
polypeptide, sealed storage, away from moisture and light
- 英文名:
RC160; BMY 41606
- 库存:
货期:1-2天
- 供应商:
MedChemExpress LLC
- CAS号:
103222-11-3
- 规格:
5 mg/10 mg/25 mg/50 mg
| 规格: | 5 mg | 产品价格: | ¥800.0 |
|---|---|---|---|
| 规格: | 10 mg | 产品价格: | ¥1300.0 |
| 规格: | 25 mg | 产品价格: | ¥2500.0 |
| 规格: | 50 mg | 产品价格: | ¥4000.0 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
Vapreotide
CAS No. : 103222-11-3
MCE 国际站:Vapreotide
产品活性:Vapreotide 是 神经激肽-1 (NK1) 受体拮抗剂,其 IC50 值为 330 nM。
研究领域:GPCR/G Protein | Neuronal Signaling
作用靶点:Neurokinin Receptor
In Vitro: Vapreotide attenuates the effect of SP on calcium release in a concentration-dependent manner. The concentration required for Vapreotide to completely inhibit the effect of SP is about 100 times higher than that required for the NK1R antagonist aprepitant. The effect of Vapreotide on cell proliferation is mediated primarily by SSTR2. In order to further establish the NK1R antagonist effect of Vapreotide, U373MG cells are pretreated with SSTR2 selective antagonist CYN followed by incubation with Vapreotide and SP stimulation. The results show that pretreatment with CYN does not reverse the inhibitory effect of Vapreotide on SP-stimulated IL-8 mRNA expression. Vapreotide reduces HIV-1 replication in MDM as indicated by limited HIV gag mRNA expression compared to control MDM. In addition, SP treatment (10 μM) reverses Vapreotide inhibition of HIV-1 replication in MDM. This observation indicates that the inhibition of HIV-1 replication by Vapreotide is most likely due to its interaction with NK1R.
相关产品:Drug Repurposing Compound Library Plus | FDA-Approved Drug Library Plus | Bioactive Compound Library Plus | GPCR/G Protein Compound Library | Neuronal Signaling Compound Library | FDA-Approved Drug Library | Anti-Cancer Compound Library | Drug Repurposing Compound Library | Anti-COVID-19 Compound Library | Neurotransmitter Receptor Compound Library | FDA Approved & Pharmacopeial Drug Library | Rare Diseases Drug Library | Peptide Library | Substance P | Aprepitant | Fezolinetant | Netupitant | Senktide | Rolapitant | Pavinetant | Neurokinin A TFA | Saredutant | L-732138 | Fosaprepitant dimeglumine | Maropitant | SB-222200 | Talnetant | Neurokinin B TFA | Vofopitant dihydrochloride | Tradipitant | Eprazinone dihydrochloride | Hemokinin 1 (mouse) | NKP608 | Men 10376 TFA | Osanetant | Y1 receptor antagonist 1 | Elinzanetant | [Sar9,Met(O2)11]-Substance P TFA | Casopitant mesylate | Neurokinin A(4-10) TFA
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 染料试剂 | PROTAC | 同位素标记物 | 寡核苷酸
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
品牌介绍:
• MCE (MedChemExpress) 拥有数百种全球独家化合物,我们致力于为全球科研客户提供前沿最全的高品质小分子活性化合物;
• 10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域;
• 设有专业的实验中心和严格的质控、验证体系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告,确保产品的高纯度、高品质;
• 产品的生物活性多经各国客户实验验证;
• Nature, Cell, Science 等多种TOP期刊及制药专利收录了MCE客户的科研成果;
• 专业团队跟踪前沿的制药及生命科学研究进展,为您提供全球前沿的活性化合物;
• 与世界各大制药公司及知名科研机构建立了长期的合作。
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验,体内降解速度可通过体外降解的数据进行预测。PLGA降解产物为乳酸和羟基乙酸,这些产物在体内自然存在。 Blanco―Prieto等利用不同的PLA/PLGA微球装载生长激素抑制剂伐普肽(vapreotide),得到46%~87%的包裹率,在4周内有40%~80%的释放率,并可维持大约14天1 ng/m1的血浆水平。Wang等利用50:50的PLA/PGA珠作抑制感染的抗生素载体,可以保持较高的抗生素浓度30天。Makino等利用单分散的PLGA微球装载利福平(RFP),发现RFP的装入率
技术资料暂无技术资料 索取技术资料

















